TRIM5αrh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages

Molecular Therapy

Volumn 12, Issue 4, 2005, Pages 687-696

  Anderson, Joseph ^a   Akkina, Ramesh ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

HIV 1 restriction; HIV AIDS gene therapy; Lentiviral vector; Retroviral restriction; Transgenic macrophages; TRIM5

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYTOPLASM PROTEIN; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; CARRIER PROTEIN; TRIM5 PROTEIN, HUMAN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONKEY; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SPECIES DIFFERENCE; STEM CELL GENE THERAPY; TRANSGENE; TRANSLATION REGULATION; VIRAL GENE DELIVERY SYSTEM; VIRUS RESISTANCE; CELL DIFFERENTIATION; DRUG EFFECT; GENE THERAPY; GENE VECTOR; GENETICS; IMMUNOLOGY; LENTIVIRINAE; METABOLISM;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE; SIMIAE;

ANTIGENS, CD34; CARRIER PROTEINS; CELL DIFFERENTIATION; GENE THERAPY; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HIV-1; HUMANS; LENTIVIRUS; MACROPHAGES; RECEPTORS, CCR5; RECEPTORS, CXCR4; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 25144460493     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2005.07.291     Document Type: Article

References (50)

1. S.M. Hammer H.A. Kessler and M.S. Saag Issues in combination antiretroviral therapy: A review J. Acquired Immune Defic. Syndr. 7 1994 S24-S35
2. S.J. Potter C.B. Chew M. Steain D.E. Dwyer and N.K. Saksena Obstacles to successful antiretroviral treatment of HIV-1 infection: Problems and perspectives Indian J. Med. Res. 19 2004 217-237
3. A.K. Iversen et al. Multidrug-resistance human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy J. Virol. 70 1996 1086-1090
4. L. Monno A. Appice R. Cavaliere T. Scarabaggio and G. Angarano Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations J. Infect. Dis. 180 1999 568-571
5. W. Lewis and M.C. Dalakas Mitochondrial toxicity of antiviral drugs Nat. Med. 1 1995 417-422
6. A. Carr J. Miller M. Law and D.A. Cooper A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome AIDS 14 2000 F25-F32
7. M.H. Malim et al. Stable expression of transdominant rev protein in human T cells inhibits HIV replication J. Exp. Med. 176 1992 1197-1201
8. M.L. Bonyhadi et al. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit HIV replication J. Virol. 71 1997 4707-4716
9. R. Akkina A. Banerjea J. Bai J. Anderson M.J. Li and J. Rossi siRNAs, ribozymes, and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS Anticancer Res. 23 2003 1997-2006
10. F.K. Ngok R.T. Mitsuyasu J.L. Macpherson M.P. Boyd G.P. Symonds and R.G. Amado Clinical gene therapy research utilizing ribozymes: Applications to the treatment of HIV/AIDS Methods Mol. Biol. 252 2004 581-598
11. M.J. Li et al. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs Mol. Ther. 8 2003 196-206
12. M.A. Martinez et al. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication AIDS 16 2002 2385-2390
13. J. Anderson and R. Akkina HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector AIDS Res. Ther. 2 2005 1-12
14. J. Anderson A. Banerjea and R. Akkina Bispecific short-hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance Oligonucleotides 13 2003 303-312
15. M.M. Lee G. Coburn M.O. McClure and B.R. Cullen Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector J. Virol. 77 2003 11964-11972
16. X. Qin D.S. An I.S.Y. Chen and D. Baltimore Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 Proc. Natl. Acad. Sci. USA 100 2003 183-188
17. C.D. Novina et al. siRNA-directed inhibition of HIV-1 infection Nat. Med. 8 2002 681-686
18. J. Anderson A. Banerjea V. Planelles and R. Akkina Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA AIDS Res. Hum. Retroviruses 19 2003 699-706
19. + cells Blood 103 2004 4511-4513
20. A. Banerjea et al. Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages Mol. Ther. 8 2003 62-71
21. K. Lee and V.N. KewalRamani In defense of the cell: TRIM5alpha interception of mammalian retroviruses Proc. Natl. Acad. Sci. USA 101 2004 10496-10497
22. S. Himathongkham and P.A. Luciw Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells Virology 219 1996 485-488
23. R. Shibata H. Sakai M. Kawamura K. Tokunaga and A. Adachi Early replication block of human immunodeficiency virus type 1 in monkey cells J. Gen. Virol. 76 1995 2723-2730
24. J.A. Labonte G.J. Babcock T. Patel and J. Sodroski Blockade of HIV-1 infection of New World monkey cells occurs primarily at the stage of virus entry J. Exp. Med. 196 2002 431-445
25. S. Cowan T. Hatziioannou T. Cunningham M.A. Muesing H.G. Gottlinger and P.D. Bieniasz Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism Proc. Natl. Acad. Sci. USA 99 2002 11914-11919
26. C. Besnier Y. Takeuchi and G. Towers Restriction of lentivirus in monkeys Proc. Natl. Acad. Sci. USA 99 2002 11920-11925
27. J.P. Stoye An intracellular block to primate lentivirus replication Proc. Natl. Acad. Sci. USA 99 2002 11549-11551
28. W. Hofmann et al. Species-specific, postentry barriers to primate immunodeficiency virus infection J. Virol. 73 1999 10020-10028
29. B. Song H. Javanbakht M. Perron H. Park do M. Stremlau and J. Sodroski Retrovirus restriction by TRIM5alpha variants from Old World and New World primates J. Virol. 79 2005 3930-3937
30. M.J. Perron M. Stremlau B. Song W. Ulm R.C. Mulligan and J. Sodroski TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells Proc. Natl. Acad. Sci. USA 101 2004 11827-11832
31. M.W. Yap S. Nisole C. Lynch and J.P. Stoye Trim5alpha protein restricts both HIV-1 and murine leukemia virus Proc. Natl. Acad. Sci. USA 101 2004 10786-10791
32. Z. Keckesova L.M. Ylinen and G.J. Towers The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities Proc. Natl. Acad. Sci. USA 101 2004 10780-10785
33. T. Hatziioannou D. Perez-Caballero A. Yang S. Cowan and P.D. Bieniasz Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha Proc. Natl. Acad. Sci. USA 101 2004 10774-10779
34. T. Hatziioannou S. Cowan S.P. Goff P.D. Bieniasz and G.J. Towers Restriction of multiple divergent retroviruses by Lv1 and Ref1 EMBO J. 22 2003 385-394
35. G. Towers M. Bock S. Martin Y. Takeuchi J.P. Stoye and O. Danos A conserved mechanism of retrovirus restriction in mammals Proc. Natl. Acad. Sci. USA 97 2000 12295-12299
36. M. Stremlau C.M. Owens M.J. Perron M. Kiessling P. Autissier and J. Sodroski The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys Nature 427 2004 848-853
37. M. Stremlau M. Perron S. Welikala and J. Sodroski Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction J. Virol. 79 2005 3139-3145
38. S.L. Sawyer L.I. Wu M. Emerman and H.S. Malik Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain Proc. Natl. Acad. Sci. USA 102 2005 2832-2837
39. M.W. Yap S. Nisole and J.P. Stoye Single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction Curr. Biol. 15 2005 73-78
40. B.A. Reddy L.D. Etkin and P.S. Freemont A novel zinc finger coiled-coil domain in a family of nuclear proteins Trends Biochem. Sci. 17 1992 344-345
41. K.L. Borden RING fingers and B-boxes: Zinc-binding protein-protein interaction domains Biochem. Cell Biol. 76 1998 351-358
42. A. Reymond et al. The tripartite motif family identifies cell compartments EMBO J. 20 2001 2140-2151
43. C.M. Owens P.C. Yang H. Gottlinger and J. Sodroski Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells J. Virol. 77 2003 726-731
44. C.M. Owens B. Song M.J. Perron P.C. Yang M. Stremlau and J. Sodroski Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid J. Virol. 78 2004 5423-5437
45. N.A. Kootstra C. Munk N. Tonnu N.R. Landau and I.M. Verma Abrogation of postentry restriction of HIV-1 based lentiviral vector transduction in simian cells Proc. Natl. Acad. Sci. USA 100 2003 1298-1303
46. L. Xu et al. BTBD1and BTBD2 colocalize to cytoplasmic bodies with the RBCC/tripartite motif protein, TRIM5δ Exp. Cell Res. 288 2003 84-93
47. L.E. Ailles and L. Naldini HIV-1 derived lentiviral vectors (D. Trono, Ed.) Lentiviral Vectors 2002 Springer-Verlag Berlin 31-48
48. J. Kimpton and M. Emerman Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene J. Virol. 66 1992 2232-2239
49. M.A. Vodicka et al. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses Virology 233 1997 193-198
50. P. Yam S. Li J. Wu J. Hu J. Zaia and J. Yee Design of HIV-1 vectors for efficient gene delivery into human hematopoietic cells Mol. Ther. 6 2002 770-782